MedVi vs Ro.co: Compounded Semaglutide or Wegovy Pill Choice
Comparing MedVi vs Ro.co quickly: MedVi focuses on compounded semaglutide with a no-clinic, online process starting at $179/month and 24/7 certified support, while Ro.co starts online at $39 and is the only mainstream platform here offering the FDA-approved Wegovy pill. Early verdict: choose MedVi if you want a compounded injectable path with round the clock clinician access; choose Ro.co if you need an FDA-approved oral Wegovy option or want the lowest online entry price.
How MedVi and Ro.co differ at a glance
This comparison focuses on the most distinctive supported differences between MedVi and Ro.co: starting price and promotional structure, medication type and regulatory status, in-person requirements and care model, support and brand positioning, and shipping or fee transparency where stated.
1. Starting price and promotional structure
MedVi advertises a winter promotional starting price of $179 for the first month, including fast, free shipping. The source states the ongoing standalone month increases to $299 and a three-month plan is available at $649. Ro.co advertises you can get started online for just $39, and ongoing branded medication pricing depends on the plan. The evidence explicitly notes Ro.co’s $39 entry is a direct-pay starting point.
2. Medication type and regulatory status
MedVi provides clinically dosed compounded semaglutide. The source emphasizes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. MedVi’s platform prescribes compounded GLP-1s produced in FDA-regulated facilities but not FDA-approved individually. By contrast, Ro.co offers access to the Wegovy pill, described as the first and only FDA-approved oral GLP-1 weight loss medication. The Ro.co source highlights that the Wegovy pill is a finished branded product with regulator evaluation, while most competitors offer compounded injectable semaglutide.
3. Care model and visit requirements
MedVi emphasizes a simple online process with no clinic visits needed; clinicians review online intake and medication is shipped after clinician review. Ro.co also allows starting online for $39 and states treatment is available only when a licensed clinician determines it is medically appropriate. Both operate via clinician review, but MedVi specifically markets no in-person visits and a streamlined online intake.
4. Support, brand positioning, and trust
MedVi markets 24/7 support from certified medical professionals and frames itself as clinically dosed compounded semaglutide with telehealth oversight. Ro.co is presented as an established, full-service telehealth platform with brand trust and the unique offering of an FDA-approved oral medication. The sources present MedVi as strongest for simplicity and 24/7 support, and Ro.co as strongest for regulatory clarity and an injection-free Wegovy pill.
5. Shipping, fees, and transparency
MedVi explicitly states fast, free shipping for the promotional price and notes medication is included in the cost of the MEDVi Program. Ro.co’s capture does not verify shipping details on the captured page but states there are no hidden fees and pricing is disclosed before consultation. For shipping and ongoing fee specifics, the Ro.co source did not provide verified shipping details on the captured landing page.
| Criteria | MedVi | Ro.co |
|---|---|---|
| Starting price | Winter promo starting at $179 for first month | Get started online for just $39 |
| Medication type | Compounded semaglutide (not FDA-approved as compounded) | Wegovy pill, FDA-approved oral GLP-1 |
| Clinic visits | No clinic visits required; online intake and clinician review | Online start; treatment if licensed clinician determines appropriate |
| Support | 24/7 certified medical support advertised | Full-service platform with brand trust; support implied |
| Shipping and fees | Fast, free shipping included in promo | No hidden fees claimed; shipping not verified on captured page |
Direct comparison summary
MedVi vs Ro.co boils down to choosing between a compounded injectable pathway with promotional pricing and round the clock support, and a branded FDA-approved oral option with a lower online entry fee. MedVi is explicit about its $179 promotional first month, no clinic visits, and 24/7 certified support, while also noting compounded medications are not FDA-approved. Ro.co is explicit about offering the Wegovy pill, FDA-approved oral semaglutide, and a $39 online start, with ongoing branded medication costs varying by plan.
Explore MedVi’s compounded semaglutide program
How to decide
Choose based only on the supplied evidence: if injection aversion or preference for an FDA-approved finished product matters most, Ro.co’s Wegovy pill and oral option are uniquely supported in the source. If you prefer a streamlined online intake, no clinic visits, 24/7 certified support, and a low promotional first month with fast, free shipping, MedVi is presented as the tailored choice.
Conclusion
MedVi vs Ro.co centers on compounded semaglutide starting at $179/month with no clinic visits and 24/7 support versus Ro.co’s $39 online start and unique access to the FDA-approved Wegovy pill. Choose MedVi if you want a compounded semaglutide path with continuous clinician access and a promotional first month. Choose Ro.co if you want the FDA-approved oral Wegovy option or the lowest advertised online entry price. The comparison above uses only the supplied source statements and qualifiers.